{"cdcTestId":"2022-0024","testcaseName":"Patient is 6 years of age and is administered Jansen as dose #1 and administered doses #2 and #3 as Pfizer Covid-19 vaccine","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2016-07-27T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-07-27T00:00:00","vaccineName":"Janssen (J\u0026J) COVID-19 Vaccine","cvx":"212","mvx":"JSN","evaluationStatus":"Not Valid","evaluationReason":"Not a preferable or allowable vaccine"},{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2022-12-14T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-07-27T00:00:00","vaccineName":"Janssen (J\u0026J) COVID-19 Vaccine","cvx":"212","mvx":"JSN","evaluationStatus":"Not Valid","evaluationReason":"Not a preferable or allowable vaccine"},{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-10-19T12:16:38.385","generalDescription":"This test case describes when a patient that is 6 years of age is administered the Janssen Covid-19 vaccine as a first dose and Pfizer Covid-19 vaccine as the second and third dose, that the first dose is not valid.  A booster dose should be forecast.","changedInVersion":"4.28","reasonForChange":"v4.28 Updated the test cased based on new updated Interim Clinical Considerations for a new COVID-19 booster recommendation for people ages 5 years and older to receive 1 bivalent MRNA booster dose, at least 2 months, after completion of a monovalent primary series; these recommendations replace all booster recommendations for this age group.\nv4.26 Updated vaccine dose status in dose #1 from \u0022valid\u0027 to \u0022not valid\u0022 for Janssen based on current Covid-19 Clinical Consideration guidelines comments, found in Table C."}